Toward the development of an innovative pharmacological compound employing peptides for EGFR-mediated drug delivery in anaplastic thyroid carcinoma. - Kahvecioglu ZC; Vandecasteele S; Bougard M; Rasson O; Nachtergael A; Duez P; Nonclercq D; Remmelink M; Laurent S; Saussez S; Burtea C (Biochemical pharmacology, 2026)